MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. - Wikidata - wikimedia - TriplyDB

MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.

MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q37059144

about

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition Mucin-based targeted pancreatic cancer therapy Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134.A tumor specific antibody to aid breast cancer screening in women with dense breast tissue MUC1: a multifaceted oncoprotein with a key role in cancer progression.Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Genetically engineered mucin mouse models for inflammation and cancer.MUC1 regulates PDGFA expression during pancreatic cancer progression Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.Genetically engineered mouse models of pancreatic cancer.Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.Immunobiology of human mucin 1 in a preclinical ovarian tumor model.Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population.MUC1 immunotherapy.Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.Mucins in pancreatic cancer and its microenvironment.Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Mucins and pancreatic cancer.The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host.

P2860

Q24632480-F3034575-3D32-4597-A0C8-B43FA72EEAC8 Q26861761-34E62ACC-3184-4BB4-8A21-67089BA451E1 Q33624574-6784A8FF-CC5D-40F8-B0A7-835F24898330 Q33849311-820F87E6-2926-40AF-8308-FEEEFC7461E4 Q33849708-C6FB5524-6418-411F-97DA-8426B7E68A6F Q33880143-99F163F7-229D-45DE-8F01-6B98350AFE7E Q34000467-B4865EBA-11BB-4636-9FD6-6F76DCB9BD7B Q34898405-BFC4B5EF-CD3C-4D8C-811B-C888F2757607 Q35035389-FBBB3408-410F-4F54-BFCC-77577220A7A8 Q35605048-06CCC3CC-8F7C-413C-9FA7-EE27653AD2D7 Q35749993-D4909732-49D2-45BE-B983-00F627D654BD Q35846935-8842DA10-A3F0-4716-A396-07AE1EB76024 Q35870682-6730543F-0471-4516-A306-CF6376537BA0 Q35904634-7FF5764B-80D3-4F77-B313-2AA0C9BBB02D Q35916552-3F6DF61D-FFBD-47C0-9C0C-4C581404F389 Q36249357-7DA470F5-AB47-4BC1-B5A2-6885D7F49363 Q36249508-2DECCEC4-1B8F-4351-AA5D-449B383DB653 Q36437150-C1F25250-552E-420D-974F-B0831E7A5C11 Q36675786-5C18F455-2E75-4DBD-AE35-2B6CD06F1E75 Q37047682-0BB5CFB7-9D0F-49E4-9530-AC1ED069508A Q37087112-25D712B7-62BC-45C9-9265-A1CFC15CB274 Q37123143-91895C6C-4318-4771-95C2-F8F4CF099FCB Q37124065-B4C99D34-9BEF-4A5F-8DB6-CF1E544BBC09 Q37249025-E4D9C80F-10F1-4A97-824E-C11016E2F1C3 Q37322304-7CC9ACE8-31BF-4B5A-BC0F-5720A3C3FBC9 Q37338140-5BA4024F-43D8-4147-8634-75B3B62AC476 Q37376094-7D7B639F-50A5-4888-A7DB-9F744FB4F616 Q37381597-C2232971-AFDF-4416-B832-AB78DC97EDB4 Q37411831-3164B6DA-A5A2-4EFF-8DEE-A406FDE18E8D Q37434103-9982B5B9-9229-478C-9725-756D544C93E7 Q37522460-1FEDE42A-BCFB-41A0-951C-2B23E08B8BFC Q37527861-D0369ECA-D6C5-40B8-B6FE-ACA12F838DAD Q37598872-C4B54B80-5378-4480-A8DA-4CFF8006434D Q37773241-A98E836A-5B6A-43D6-AD71-0D78EEB029AF Q38097532-95F25DA2-B3C1-4645-A68E-EB805C9A7C2C Q38121746-CBF04DE5-C0A3-4BDE-8F01-032082702F4E Q38142315-0B47622A-96C8-446C-8452-8D2C1DD83705 Q38162151-F7D4B413-541D-422E-BB94-75343C69001B Q38166583-078621F8-9157-4CC4-8488-BC3CC5FB5C50 Q38181143-C682FFEA-5B08-45C8-BDE3-759E96F696F4

P2860

MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q37059144

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@en

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@nl

type

label

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@en

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@nl

prefLabel

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@en

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@nl

P1433

Q37059144-7158DEFC-6750-4596-BF32-B3BB84A58E17

P1476

Q37059144-B9FBA561-D4E8-4755-B71E-40BD98EF7661

P2093

Q37059144-2FC0CA3C-ADEE-44C8-B73C-DC3C7451C6B1

Q37059144-498B0C5B-3D03-4C71-BF2F-3B03B2068266

Q37059144-63AFFDCB-D0CD-4346-B4C0-5903AF0C0D4C

Q37059144-9F4E91D8-C214-4712-A215-CD5DC6CD401B

Q37059144-A5AD7C9D-0E47-451A-9500-580054D61BCC

Q37059144-B0258529-C6BD-4497-9C6D-DABBD9407E6B

Q37059144-F0ED26E0-B020-4474-8FA2-56B20A7F72B5

Q37059144-F6D23DF4-0EAE-4FAE-A5A1-BF64307B9623

P2860

Q37059144-062DF2C2-D784-45F6-98E7-BAEBC57DC45C

Q37059144-06F8D951-5368-4FF4-8F39-23106676CA22

Q37059144-0D64948A-5764-4CCE-8750-691CED2F5BD5

Q37059144-0E669F1B-E2FC-4178-BB3C-5A734008D42C

Q37059144-0EC4532A-F1CD-4B84-AAC7-8E61805BFD06

Q37059144-13D74134-2C76-46B5-987D-5064DFAFFE19

Q37059144-24947A61-6149-41D2-AD5B-796D815286CB

Q37059144-26C3088A-3C0C-488D-8B66-63A25B424988

Q37059144-2A234290-EF65-4355-BB82-A70CB14E490D

Q37059144-33447D5C-96C9-435A-90E6-E461D41FD877

P304

Q37059144-D685C6B3-E5F8-474E-99AC-8AA7B721ED88

P31

Q37059144-06ECC2DA-2BD5-43E9-B386-EB938F005723

P356

Q37059144-DBB7ED69-297B-4052-84A3-0A0136388343

P407

Q37059144-757EE307-DD95-4BE8-886A-305A2BC08760

P433

Q37059144-05E871BF-D9BC-48A7-AE40-5926AF5C1B25

P478

Q37059144-BF66010E-E872-4979-A680-03681719B89F

P577

Q37059144-F64991C0-166D-4661-BD8D-56449E96B8C4

P5875

Q37059144-620B3E6F-999F-4726-8466-453C605541E6

P698

Q37059144-83B32B32-5C1C-425E-92D3-BC42CE13F14D

P921

Q37059144-73554EA6-0C24-4442-BEB9-852567EE209D

Q37059144-C7E2BDA0-3AE5-4EA0-9E7F-9C97B1146A6D

P932

Q37059144-46519D52-0F80-42C1-9B2C-BA8E73246792

P356

JIMMUNOL.181.5.3116

P1433

Journal of Immunology

P1476

MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.

@en

P2093

Arefayene Million

http://www.w3.org/2001/XMLSchema#string

Durai B Subramani

http://www.w3.org/2001/XMLSchema#string

Gargi D Basu

http://www.w3.org/2001/XMLSchema#string

Jorge Schettini

http://www.w3.org/2001/XMLSchema#string

Judy M Bradley

http://www.w3.org/2001/XMLSchema#string

Pinku Mukherjee

http://www.w3.org/2001/XMLSchema#string

Teresa L Tinder

http://www.w3.org/2001/XMLSchema#string

Todd Skaar

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin

The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

MUC1, the renaissance molecule

IDO expression by dendritic cells: tolerance and tryptophan catabolism

Cancer statistics, 2006

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.

P304

3116-3125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.181.5.3116

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23181243

http://www.w3.org/2001/XMLSchema#string

P698

18713982

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

2625292

http://www.w3.org/2001/XMLSchema#string